MedTrace Logo

Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis

NCT02125812 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-06-02

No results posted yet for this study

Summary

The adjunctive use of systemically administered antibiotics has been shown to provide a better clinical outcome, particularly in terms of probing depth (PD) reduction and attachment-level gain than SRP in subjects with Aggressive Periodontitis.

The overall objective of this study is to evaluate the clinical and microbiological efficacy of moxifloxacin as an adjunct to scaling and root planing versus scaling and root planing over placebo in the treatment of aggressive periodontitis.

Conditions

  • Aggressive Periodontitis

Interventions

OTHER

scaling and systemic moxifloxacin

scaling and root planing (SRP) combined with systemic moxifloxacin

OTHER

scaling and root planing

scaling and root planing

Sponsors & Collaborators

  • Universidad de Antioquia

    collaborator OTHER

  • Facultad Nacional de Salud Publica

    lead OTHER

Principal Investigators

  • Carlos M Ardila, Ph.D · Universidad de Antioquia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-03-31
Completion
2014-04-30

Countries

  • Colombia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02125812 on ClinicalTrials.gov